C9 and amyotrophic lateral sclerosis: COs were grown up to 240 DIV at the air–liquid interface (ALI-COs) from iPSCs derived from patients with ALS/FTD, harboring the C9ORF72 hexanucleotide repeat expansion mutation (C9 ALI-COs).